published their experience with cisplatin and infusional 5-fl uorouracil as induction chemotherapy for head and neck squamous cell car-cinoma. They found that in previously untreated patients, induc-tion chemotherapy with cisplatin and 5-fl uorouracil was associated with response rates as high as 94 % and that those responding to induction chemotherapy also proved to be good candidates for subsequent radiotherapy. These results were followed by th
Background: Concurrent chemoradiotherapy with the single agent cisplatin (CDDP þ RT) has been recogn...
Purpose The purpose of this study was to compare the survival of patients with locally advanced head...
PURPOSE: To study the feasibility of induction chemotherapy added to concomitant cisplatin-based che...
BACKGROUND: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radi...
Background: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radi...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Purpose: The purpose of this study was to determine if a combination chemotherapy, using continuous ...
Objective: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) for locally advanced ...
PURPOSE: Despite the lack of evidence to support its implementation in the clinical practice, induct...
The role of chemotherapy as part of a larynx sparing treatment strategy for advanced laryngeal cance...
BACKGROUND: This study evaluated the feasibility, toxicity, response rate and survival of neoadjuvan...
Purpose: This phase II trial was designed to evaluate efficacy and safety of a highly intensified th...
Abstract: Background. Patients with head and neck cancer and good pathologic response to neoadjuvant...
Abstract: Background. Determining which patients benefit from larynx preservation strategies remains...
Background: Concurrent chemoradiotherapy with the single agent cisplatin (CDDP þ RT) has been recogn...
Purpose The purpose of this study was to compare the survival of patients with locally advanced head...
PURPOSE: To study the feasibility of induction chemotherapy added to concomitant cisplatin-based che...
BACKGROUND: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radi...
Background: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radi...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Purpose: The purpose of this study was to determine if a combination chemotherapy, using continuous ...
Objective: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) for locally advanced ...
PURPOSE: Despite the lack of evidence to support its implementation in the clinical practice, induct...
The role of chemotherapy as part of a larynx sparing treatment strategy for advanced laryngeal cance...
BACKGROUND: This study evaluated the feasibility, toxicity, response rate and survival of neoadjuvan...
Purpose: This phase II trial was designed to evaluate efficacy and safety of a highly intensified th...
Abstract: Background. Patients with head and neck cancer and good pathologic response to neoadjuvant...
Abstract: Background. Determining which patients benefit from larynx preservation strategies remains...
Background: Concurrent chemoradiotherapy with the single agent cisplatin (CDDP þ RT) has been recogn...
Purpose The purpose of this study was to compare the survival of patients with locally advanced head...
PURPOSE: To study the feasibility of induction chemotherapy added to concomitant cisplatin-based che...